Yield10 Bioscience Inc reports results for the quarter ended in March - Earnings Summary

Yield10 Bioscience

12/05/2021 24:42

* Yield10 Bioscience Inc  YTEN.OQ  reported a quarterly adjusted
loss of 60 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 56 cents per share.
* Revenue rose 9.5% to $196.00 thousand from a year ago; 
analysts expected $218.00 thousand. 
* Yield10 Bioscience Inc's reported EPS for the quarter was a
loss of 60 cents​.
* The mean earnings estimate of analysts had risen by about 14%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Yield10 Bioscience Inc shares had fallen by 22.9% this
quarter and gained 67.3% so far this year.
* The company reported a quarterly loss of $2.56 million.
* Wall Street's median 12-month price target for Yield10
Bioscience Inc is $25.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 11:42 p.m. GMT.
​All figures in US dollars